Glenmark Pharmaceuticals receives USFDA approval for Aspirin and Extended‐Release Dipyridamole Capsules
Glenmark Pharmaceuticals Receives ANDA Approval for Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg
IT major Tata Consultancy Services (TCS) announces its Q1 June 2019 result today, 9 July 2019.
Hero MotoCorp has made an upward revision in the ex-showroom prices of its motorcycles and scooters, effective 8 July 2019. The price increase across its range of two-wheelers has been 1% (of the exshowroom price), although the exact quantum of the increase will vary on the basis of the model and the specific market. The announcement was made after market hours yesterday, 8 July 2019.
Titan Company in its quarterly update said that the Q1 June 2019 witnessed a tough macro-economic environment with consumption being hit. Very high gold prices particularly in June also impacted growth in the Jewellery industry. Against this background, the company's growth particularly in the Jewellery segment was lower than planned even though the gains in market share were sustained. The announcement was made after market hours yesterday, 8 July 2019.
Glenmark Pharmaceuticals' subsidiary Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Ranolazine Extended-Release Tablets, 500 mg and 1,000 mg, a generic version of Ranexa Extended-Release Tablets, 500 mg and 1,000 mg, of Gilead Sciences, Inc. The announcement was made before market hours today, 9 July 2019.
Voltas announced its partnership with Energy Efficiency Services (EESL) to manufacture and sell 5-star rated Inverter Air Conditioners. The announcement was made before market hours today, 9 July 2019.
Fortis Healthcare said that Fortis Healthcare International (FHIL), a wholly owned subsidiary of the company, which is incorporated in Mauritius, has consummated the Proposed Transaction of sale of the entire shareholding held by FHIL in The Medical and Surgical Centre (MSCL), representing 28.89% stake. The announcement was made after market hours yesterday, 8 July 2019.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)